Aim: To examine if isoflurane preconditioning can attenuate ischemia/reperfusion injury by reducing cytochrome c release from inner mitochondrial membrane. Methods: Isolated hearts of Sprague-Dawley rats were perfused on Langendorff apparatus. Hearts were randomly assigned to a non-treated group (CON group, n=12) or three isoflurane preconditioning groups (0.5% ISC group, 1.0% ISC group, and 2.0% ISC group; n=12). In the latter three groups, isoflurane was given at concentrations of 0.5%, 1.0%, and 2.0% for 15 min with 15-min washout before 30-min ischemia. Subsarcolemmal mitochondria of the myocardium were isolated after 60-min reperfusion. Hemodynamics of the each heart was recorded, infarct size of the hearts and contents of cytosolic cytochrome or mitochondrial cytochrome c were measured at the end of reperfusion. Morphology of isolated mitochondria in the four groups was evaluated, respectively. Results: Compared with the CON group, cytosolic cytochrome c in 0.5% ISC group, 1.0% ISC group, and 2.0% ISC group were significantly decreased along with a significant increase of mitochondrial cytochrome c. Infarct size of the hearts in the four groups were 56%±12%, 41%±12%, 32%±7% and 33%±11%, respectively. The values of the three isoflurane preconditioning groups were significantly lower than that of the CON group (P<0.05). Isoflurane exposure before ischemia can attenuate the change of morphology of mitochondria after reperfusion. The effects of 2.0% isoflurane on reducing cytochrome c release were more remarkable than 0.5% and 1.0% concentrations of isoflurane. Conclusion: Myocardioprotective effects of isoflurane preconditioning were associated with attenuation of cytochrome c loss from the inner membrane of subsarcolemmal mitochondria.
Introduction
Volatile anesthetics can protect against reperfusion injury after myocardial ischemia in vitro and in vivo [1] [2] [3] [4] . And isoflurane is one of the drugs most commonly used to maintain the state of general anesthesia. Isoflurane preconditioning, a temporary exposure to isoflurane followed by its complete washout, can protect against cardiac ischemiareperfusion injury. It has been reported that isoflurane preconditioning can mimic ischemia preconditioning to protect against reperfusion injury after myocardial ischemia in vitro and in vivo [3, 4] . However, to date, the mechanism of isoflurane preconditioning remains unclear. It has been reported that ischemic preconditioning can induce mitochondrial tolerance by using the loss of cytochrome c as an indication of mitochondrial dysfunction [5] . It is not known whether the cardioprotective effect of isoflurane preconditioning can also be achieved by inducing mitochondrial tolerance.
Mitochondria sustains progressive damage during ischemia. Cardiac mitochondria exist in two functionally distinct populations. Subsarcolemmal mitochondria (SSM) are located beneath the plasma membrane, whereas interfibrillar mitochondria (IFM) are located between the myofibrils. These two mitochondria are affected differently in myocardiopathy and ischemia. The progression of ischemic damage is more rapid in SSM [6, 7] In the present study, we examined if isoflurane preconditioning protected against a detrimental ischemic insult by attenuating cytochrome c release from the inner membrane of subsarcolemmal mitochondria
Materials and methods
Isolated heart preparation and measurements Experiments were performed on adult male Sprague-Dawley rats weighing 230-300 g. The rats were housed in plastic cages with soft bedding and free access to food and water under a 12-h day/12-h night cycle. Rats were supplied by the Experimental Animal Center of Xuzhou Medical College. All experiments were approved by the Animal Care and Use Committee at the college and were in accordance with the Guidelines for Care and Use of Laboratory Animals. Pentobarbital 40 mg/kg and heparin 500 U/kg were injected intraperitoneally into 44 Sprague-Dawley rats weighing 250-300 g. After thoracotomy, the hearts were isolated and immediately placed in 4 °C Krebs-Henseleit (K-H) solution, then rapidly prepared using the Langendorff method and perfused at 55 mmHg with K-H solution at 37 °C. The perfusate was equilibrated with mixed gas of 95% O 2 and 5% CO 2 to meet standards (pH, 7.4±0.02; carbon dioxide partial pressure, 25±4 mmHg; oxygen partial pressure, 570±20 mmHg). The composition of K-H perfusate was as follows: NaCl 118 mmol/L, KCl 4.7 mmol/L, KH 2 PO 4 1.2 mmol/L, CaCl 2 2.5 mmol/L, MgSO 4 1.2 mmol/L, NaHCO 3 25 mmol/L, glucose 11.1 mmol/L, Na 2 -EDTA 0.125 mmol/L.
Left ventricular pressure (LVP) and dp/dt were measured isovolumetrically with a saline-filled latex balloon inserted into the left ventricle through a cut in the left atrium. At the beginning of the experiment, the balloon volume was adjusted to achieve a diastolic LVP of 0 mmHg, so that any subsequent increase in diastolic LVP indicated an increase in left ventricular wall stiffness or diastolic contracture. Baseline hemodynamics were recorded 20 min after stabilization. Hearts were randomly assigned to a non-treated group (CON group, n=12) or three isoflurane preconditioning groups (0.5% ISC group, 1.0% ISC group and 2.0% ISC group; n=12) and were perfused with K-H solution saturated with 0.0%, 0.5%, 1.0%, and 2.0% isoflurane, respectively, for 15 min and followed by a 15-min washout with normal K-H solution before 30 min ischemia and 60 min reperfusion. Isoflurane was bubbled into the perfusate with an isoflurane vaporizer (Ohmeda, West Yorkshire, England) placed in the oxygen-carbon dioxide gas mixture line. Vapour concentrations were measured continuously by an anesthetic gas detector (Capnomac; Ultima, Datex-Engstrom, Helsinki, Finland). LVP, dp/dt, and HR were monitored continuously during the whole experiment using Maclab 4.0 software (AD Instruments, Australia).
Measurement of infarct size The 2,3,5-triphenyltetrazolium chloride (TTC) staining technique was used to determine infarct size after 60-min reperfusion. Fresh TTC was prepared in 0.1 mol/L phosphate buffer adjusted to pH 7.4. TTC stained the non-infarcted myocardium a bright red color, caused by reduction of TTC by dehydrogenases present in viable tissues. Hearts stored at -70 °C after each experiment were taken up and sliced into 4-6 transverse sections (3-mm thickness). The sections were immersed in 1% TTC solution and incubated for 30 min at 37 °C. All slices were digitally imaged by a photoscanner [8] , and the infarcted areas of each slice were measured in a blinded fashion by planimetry using Imagemaster VDS (Pharmacia Bioter, USA).
Isolation of subsarcolemmal rat heart mitochondria and cytosolic fractions Subsarcolemmal mitochondria were isolated from the ventricles as follows: the ventricles were rapidly dissected and rinsed in ice-cold homogenization buffer (CP1: KCl 100 mmol/L, MOPS 50 mmol/L, MgSO 4 5.0 mmol/L, edetic acid 1.0 mmol/L, ATP 1.0 mmol/L, at pH 7.4). The ventricles were blotted dry, weighed, minced, and washed with CP1. The mince was homogenized at 20 mL/g tissue in cold CP2 (CP1+BSA 2.0 g/L). The homogenate was then centrifuged at 584×g for 10 min. The supernatant was filtered through double layer gauze and centrifuged at 3015×g for 10 min. The mitochondrial pellet was resuspended in 5 mL CP2 per gram of heart and centrifuged at 3015×g for 10 min, and finally subsarcolemmal mitochondria were resuspended in 2.5 mL KME (100 mmol/L KCl, 50 mmol/L MOPS, 5 mmol/L egtazic acid) per gram of heart and centrifuged at 3 015×g for 10 min. Subsarcolemmal mitochondria was resuspended into KME at a final protein concentration of approximately 1.5 g/L. The first 3015×g supernatant represented the cytosolic fraction (protein concentration of approximately 2.0 g/L). All manipulations were carried out at 4 °C. Protein concentration was determined using Bradford assay, with BSA as standard.
Detection of cytochrome c by Western blotting Mitochondria prepared from isolated rat hearts were added 0.25% volume of 2×sample buffer (250 mmol/L Tris-HCl, 8.0% SDS, 700 mmol/L sucrose, 300 mmol/L DTT, 0.01% bromophenol blue, at pH 6.8). Samples were loaded onto 15% Tris-buffered polyacrylamide gels and component proteins resolved by SDS-PAGE. Proteins were electroblotted onto a nitrocellulose membrane and cytochrome c was detected using monoclonal anti-cytochrome c (Santa Cruz Biotechnology, Inc, USA) as primary antibody and anti-mouse IgG conjugated to alkaline phosphatase as secondary antibody. Primary antibody binding was visualized with an alkaline phosphatase based chemiluminescence system.
Electron microscopy Mitochondria isolated from the myocardium in several kinds of buffer by density centrifugation was resuspended and fixed with 2% glutaraldehyde in 0.1 mol/L PBS buffer. Mitochondria were post-fixed using 1% OsO 4 . En bloc staining with uranyl acetate was followed by dehydration and embedding. Embedded samples were sectioned and affixed to grids according to standard protocols. Mitochondrial ultrastructure was then evaluated by transmission electron microscopy.
Statistical analysis All data were expressed as mean± SD. Statistical analysis of data within and between groups was performed with analysis of variance (ANOVA) for repeated measures followed by Turkey multiple-comparison post-hoc test. P<0.05 was considered statistically significant. Figures 1-3 show changes in LVP, dp/dt min , dp/dt max , and HR of hearts in each of the four groups during the time course of the experiment. There was no difference in baseline hemodynamics among experimental groups. A concentration-dependent depression of left ventricular systolic pressure (LVSP), dp/dt max , and heart rate was observed after 15 min of isoflurane treatment. After 60 min of reperfusion, hemodynamic function decreased in each group compared with baseline values. Left ventricular end diastolic pressure (LVEDP) was lower in the three isofluranepreconditioning groups than in the CON group at 30 and 60 min reperfusion, but there was no significant difference in LVSP, dp/dt min, dp/dt max , and HR among the four groups.
Results

Changes in hemodynamics
Infarct size Figure 4 shows that the infarct size of the CON group was 56%±12%, isoflurane-preconditioning (0.5%,1.0%, and 2.0 %) significantly reduced infarct size to 41%± 12%, 32%±7%, and 33%±11%, respectively (P<0.05). But there was no significant difference among the three isoflurane-preconditioning groups.
Morphology of isolated mitochondria Electron microscopy analysis (×10 000) reveals basically formed membranes and clearly discernable cristae in the mitochondria isolated from hearts. The outer membranes of mitochondria isolated from CON groups were partly disrupted, and mitochondria were severely swollen, with fragmentation of the cristae. Isoflurane preconditioning attenuated morphological changes of mitochondria after ischemia and reperfusion. Mitochondria in the 2% isoflurane-preconditioned group appeared to be morphologically better than those of the other preconditioning groups. Western blot analysis of the release of mitochondrial cytochrome c Isoflurane-preconditioning reduces ischemia reperfusion-induced cytochrome c release from the mitochondria in a concentration-related manner. The results showed the amounts of cytosolic cytochrome c significantly decreased (P<0.05 vs CON group) in an isoflurane concentration-related manner, while the amounts of mitochondrial cytochrome c markedly increased (P<0.05 vs CON group). The results indicate that mitochondrial dysfunction occurred after reperfusion and was attenuated by isoflurane-precon- Figure 2 . Time course of dp/dt max (contractility) and dp/dt min (relaxation) in CON group and isoflurane preconditioning groups. dp/dt max and dp/dt min were depressed during isoflurane exposure. During the early reperfusion, the contraction and relaxation indices were improved in isoflurane preconditioning group compared with non-treated ischemia hearts, but no significant difference between the isoflurane preconditioning groups was observed at the end of the experiments. n=10. Mean±SD.
b P<0.05 vs CON. ditioning ( Figure 6 ).
Discussion
In the present study, by Western blot examining of cytochrome c in mitochondria and cytosol, we observed that isoflurane increased the content of cytochrome c in mitochondria while reduced it in cytosol in a concentration-dependent manner. Isoflurane at concentration of 2% showed the most significant effect on cytochrome c loss in the mitochondria. Furthermore, mitochondria isolated from three isoflurane preconditioning groups were morphologically better than that isolated from CON. Similarly, isoflurane preconditioning significantly reduced the infarct size of hearts at the end of reperfusion. Therefore, we concluded that cytochrome c release from the mitochondria played a key role in the pathogenesis of ischemia/reperfusion injury and myocardioprotective effects of isoflurane preconditioning were associated with the attenuation of cytochrome c loss from the inner membrane of subsarcolemmal mitochondria.
Cytochrome c is a 12-kDa protein which functions in the mitochondrial electron transport chain. At physiological ionic strength, cytochrome c diffuses in the aqueous phase between the inner and outer membranes (outer compartment) and between complex III (cytochrome bc 1 ) and complex IV (cytochrome aa 3 ). But as a small and water-soluble molecule, cytochrome c is easier to be released from mitochondria than other mitochondrial proteins. Studies have shown that the loss of cytochrome c from mitochondria could occur during ischemia and after reperfusion [9, 10] . Ischemia tolerance induced by sublethal ischemia is associated with mitochondrial protection (attenuating cytochrome c release from mitochondria) in vitro and in vivo [5] . Increasing evidence suggests that lethal reperfusion injury possibly consists of two forms of cell death, necrosis and apoptosis. The apoptotic process is initiated shortly Figure 5 . Electronic micrographs of mitochondria isolated from myocardium of CON group and isoflurane preconditioning groups. ×10 000.
after the onset of ischemia, and becomes markedly enhanced during reperfusion. Inhibition of the apoptotic process can then attenuate irreversible injury in connection with reperfusion [11] . One of the main mechanisms of cellular death induced by ischemia/reperfusion appears to be mitochondrial dysfunction. The cytochrome c release from mitochondria is a rapid and apoptosis-specific process within 1 h after the induction of apoptosis [12] . In the process of apoptosis, cytochrome c is released from the mitochondria to cytosol and caspase-3 is activated [13] . At the same time, the loss of cytochrome c could also lead to the formation of free radicals, and disturbances of oxidative phosphorylation. Whether the release of cytochrome c leads to necrotic or apoptotic cellular death depends largely on intracellular ATP levels. Most of this protein release from mitochondria to cytosol results in ATP depletion associated with necrotic cell death. Therefore, loss of cytochrome c is considered to be an indication of mitochondrial dysfunction [14, 15] . Our results show a possible involvement of mitochondria in the cellular death pathway that is initiated during ischemia/reperfusion. Compared with the other groups, more cytochrome c of CON group was released from mitochondria to cytosol. Also the infarct size in the CON group was higher than those of the isoflurane preconditioning groups. Isoflurane preconditioning attenuated cytochrome c release along with reduced infarct size. Our study demonstrates for the first time in isolated hearts that isoflurane preconditioning is able to attenuate cytochrome c release from mitochondria in a concentration-dependent manner. Meanwhile, isoflurane preconditioning significantly deceased infarct size and morphologically ameliorated mitochondria injury suffered from ischemia and reperfusion. This result also indicated that the redistribution of cytochrome c was highly correlated with cellular death.
The mechanism by which isoflurane preconditioning induces mitochondrial tolerance via attenuating cytochrome c loss is not clear. The effect of preconditioning may first be on cytosolic factors, which lead to mitochondrial tolerance that persists until mitochondria were isolated for testing. Mitochondrial ATP-sensitive potassium (K ATP ) channels appear to be involved in the process of anesthetics-preconditioning [15] [16] [17] [18] [19] [20] [21] . Recent studies have shown that activation of K ATP channels reduces the loss of mitochondrial cytochrome c through the protein kinase C signaling [22] . Anestheticinduced preconditioning reduced cytosolic Ca 2+ loading, one factor of cytochrome c release, in part through mitochondrial K ATP channels [15, 23] . Furthermore, Bcl-2 family proteins are important endogenous factors in regulating cytochrome c release from mitochondria, in which antiapoptotic proteins (eg, Bcl-2, Bcl-X L , etc) inhibit, but proapoptotic proteins (eg, Figure 6 . Western blot analysis of cytosolic and mitochondrial cytochrome c in CON group and isoflurane preconditioning groups. Left, cytochrome c from the cytosolic fraction in the control and three isoflurane preconditioning (0.5%, 1.0%, and 2.0%) groups. Right, cytochrome c from the mitochondrial fraction. The results show the amount of cytosolic cytochrome c significantly decreased by isoflurane in a concentration-dependent manner, while the amounts of mitochondrial cytochrome c markedly increased. Bax, Bad, etc) enhance, cytochrome c release [24, 25] . Therefore, the expression and redistribution of Bcl-2 family proteins is possibly another important factor of isoflurane preconditioning inducing mitochondria tolerance by attenuating cytochrome c release. There is evidence that ischemia and some pharmacological preconditioning are able to induce transcription and expression of Bcl-2 and Bcl-X L without changing transcription and the expression of Bax [26] [27] [28] . In the present study, isoflurane preconditioning reduced cytochrome c loss from mitochondria in a concentrationdependent manner. There was a remarkable reduction in cytochrome c release associated with higher concentrations of isoflurane preconditioning. However, infarct size was no further reduced by 2.0% isoflurane, which indicated that isoflurane preconditioning reduced infarct size with a peak effect at a concentration of approximately 1%. Although the release of cytochrome c from mitochondria is the main pathway of cellular death, it is not the only one. For example, members of the death receptor family, such as the Fas receptor and the tumor necrosis factor receptor also play a role in cellular death. Isoflurane preconditioning significantly attenuated cytochrome c release, but the effects of isoflurane preconditioning on other cell death signaling pathways is unclear. It is possible that other pathways of inducing cellular death contributed to the myocardial infarct in 2.0% ISC group. In the present study, however, it can be inferred that isoflurane preconditioning can protect against myocardial ischemic/reperfusion injury in part through attenuating cytochrome c loss. At the same time, it is not appropriate to tell directly whether the cytochrome c release from mitochondrial is likely to be a final step or trigger factor of myocardial injury from the present study. Further studies should be taken to examine if blocking of isoflurane preconditioning could abolish the attenuated release of cytochrome c.
In conclusion, the present study demonstrated that isoflurane preconditioning was capable of protecting against myocardium ischemia/reperfusion injury in part by attenuating the release of cytochrome c from the mitochondria.
